Efficacy of Attention Bias Modification vs. Placebo for Social Anxiety Disorder

Inclusion Criteria: * Adults aged 18-65 years * Primary diagnosis of generalized Social Anxiety Disorder based on clinical evaluation, the MINI International Neuropsychiatric Interview (MINI), and a Liebowitz Social Anxiety Scale (LSAS) score greater than 50 * Normal or corrected-to-normal vision without color blindness * Sufficient Hebrew proficiency to complete clinical interviews, self-report questionnaires, and computerized cognitive tasks Exclusion Criteria: * Previous participation in attention bias modification training using a dot-probe task * Previous participation in eye-tracking-based attention training * Current diagnosis of Post-Traumatic Stress Disorder * Current or past diagnosis of psychotic disorder or bipolar disorder * Neurological disorder (e.g., epilepsy or traumatic brain injury) * Severe suicidal ideation * Current substance or alcohol use disorder * Concurrent pharmacological or psychosocial treatment, unless medication has been stable for at least 45 days * Pregnancy * Uncorrected visual impairment or use of multifocal glasses